生长激素替代在多大程度上,通过何种机制,改善了gh缺乏成人的生活质量?

Alexandra Chrisoulidou MD (Clinical Research Fellow), Eleni Kousta MD (Clinical Research Fellow), Salem A. Beshyah PhD, MRCP (Consultant Physician) , Stephen Robinson MD, MRCP (Consultant Physician), Desmond G. Johnston PhD, FRCPath, FRCP (Professor of Clinical Endocrinology)
{"title":"生长激素替代在多大程度上,通过何种机制,改善了gh缺乏成人的生活质量?","authors":"Alexandra Chrisoulidou MD (Clinical Research Fellow),&nbsp;Eleni Kousta MD (Clinical Research Fellow),&nbsp;Salem A. Beshyah PhD, MRCP (Consultant Physician) ,&nbsp;Stephen Robinson MD, MRCP (Consultant Physician),&nbsp;Desmond G. Johnston PhD, FRCPath, FRCP (Professor of Clinical Endocrinology)","doi":"10.1016/S0950-351X(98)80022-0","DOIUrl":null,"url":null,"abstract":"<div><p>The majority of studies (but not all) have demonstrated that adults with hypopituitarism of both childhood and adult onset have a diminished quality of life (QOL) in comparison with the normal population. Reductions in physical and mental energy, dissatisfaction with body image and poor memory have been reported most consistently. A specific role for growth hormone (GH) deficiency, as opposed to multiple pituitary hormone deficiency, has been observed for the memory deficit, which extends to both short-and long-term momory. Comparisons with normal siblings have confirmed the reduced QOL, although differences have been small. There is less consensus for a reduction in QOL when hypopituitary subjects are compared with patients with other chronic diseases, with studies supporting (in comparison with diabetics) and refuting (in comparison with patients following mastoid surgery) the reduction in QOL. GH replacement in adult has improved QOL, particularly in the domains of energy level and self-esteem, and memory has improved. The social impact of these changes may be considerable, with patients requiring fewer days' sick leave. A major placebo effect is present, however, and neutral results as well as positive have been reported in placebo-controlled trials. Where a positive effect has been observed, it has been more likely to occur in patients with a low QOL at the outset. It is otherwise impossible to predict at the outset those who will benefit from GH replacement. GH treatment has effects on body composition, exercise capacity, muscle strength, total body water and intermediary metabolism which would be expected to improve QOL. Replacement therapy also has side-effects, and it is the variable balance of the positive and negative effects, coupled with the difficulties of measuring QOL, which have led to the disparate results in the literature. There is probably also a true inter-individual variation, although the mechanisms of this are currently unknown.</p></div>","PeriodicalId":77027,"journal":{"name":"Bailliere's clinical endocrinology and metabolism","volume":"12 2","pages":"Pages 261-279"},"PeriodicalIF":0.0000,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0950-351X(98)80022-0","citationCount":"22","resultStr":"{\"title\":\"5 How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults?\",\"authors\":\"Alexandra Chrisoulidou MD (Clinical Research Fellow),&nbsp;Eleni Kousta MD (Clinical Research Fellow),&nbsp;Salem A. Beshyah PhD, MRCP (Consultant Physician) ,&nbsp;Stephen Robinson MD, MRCP (Consultant Physician),&nbsp;Desmond G. Johnston PhD, FRCPath, FRCP (Professor of Clinical Endocrinology)\",\"doi\":\"10.1016/S0950-351X(98)80022-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The majority of studies (but not all) have demonstrated that adults with hypopituitarism of both childhood and adult onset have a diminished quality of life (QOL) in comparison with the normal population. Reductions in physical and mental energy, dissatisfaction with body image and poor memory have been reported most consistently. A specific role for growth hormone (GH) deficiency, as opposed to multiple pituitary hormone deficiency, has been observed for the memory deficit, which extends to both short-and long-term momory. Comparisons with normal siblings have confirmed the reduced QOL, although differences have been small. There is less consensus for a reduction in QOL when hypopituitary subjects are compared with patients with other chronic diseases, with studies supporting (in comparison with diabetics) and refuting (in comparison with patients following mastoid surgery) the reduction in QOL. GH replacement in adult has improved QOL, particularly in the domains of energy level and self-esteem, and memory has improved. The social impact of these changes may be considerable, with patients requiring fewer days' sick leave. A major placebo effect is present, however, and neutral results as well as positive have been reported in placebo-controlled trials. Where a positive effect has been observed, it has been more likely to occur in patients with a low QOL at the outset. It is otherwise impossible to predict at the outset those who will benefit from GH replacement. GH treatment has effects on body composition, exercise capacity, muscle strength, total body water and intermediary metabolism which would be expected to improve QOL. Replacement therapy also has side-effects, and it is the variable balance of the positive and negative effects, coupled with the difficulties of measuring QOL, which have led to the disparate results in the literature. There is probably also a true inter-individual variation, although the mechanisms of this are currently unknown.</p></div>\",\"PeriodicalId\":77027,\"journal\":{\"name\":\"Bailliere's clinical endocrinology and metabolism\",\"volume\":\"12 2\",\"pages\":\"Pages 261-279\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0950-351X(98)80022-0\",\"citationCount\":\"22\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bailliere's clinical endocrinology and metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0950351X98800220\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bailliere's clinical endocrinology and metabolism","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0950351X98800220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 22

摘要

大多数研究(但不是全部)表明,与正常人群相比,患有儿童期和成年期垂体功能减退症的成年人的生活质量(QOL)下降。身体和精神能量的减少、对身体形象的不满和记忆力差是最常见的。与多种垂体激素缺乏相反,生长激素(GH)缺乏对记忆缺陷的特殊作用已经被观察到,这种记忆缺陷延伸到短期和长期记忆。与正常兄弟姐妹的比较证实了生活质量的降低,尽管差异很小。与其他慢性疾病患者相比,垂体功能低下患者的生活质量降低的共识较少,有研究支持(与糖尿病患者相比)和反驳(与乳突手术后患者相比)生活质量降低。成人生长激素替代改善了生活质量,特别是在能量水平和自尊方面,记忆力得到改善。这些变化的社会影响可能是相当大的,病人需要更少的病假。然而,主要的安慰剂效应是存在的,在安慰剂对照试验中,中性结果和阳性结果都有报道。在观察到积极效果的地方,它更有可能发生在一开始生活质量较低的患者身上。否则,一开始就不可能预测哪些人将从生长激素替代中受益。生长激素治疗对机体成分、运动能力、肌力、全身水分和中间代谢均有影响,有望改善生活质量。替代疗法也有副作用,正负效应的可变平衡,再加上生活质量的测量困难,导致文献结果迥异。可能也存在真正的个体间差异,尽管其机制目前尚不清楚。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
5 How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults?

The majority of studies (but not all) have demonstrated that adults with hypopituitarism of both childhood and adult onset have a diminished quality of life (QOL) in comparison with the normal population. Reductions in physical and mental energy, dissatisfaction with body image and poor memory have been reported most consistently. A specific role for growth hormone (GH) deficiency, as opposed to multiple pituitary hormone deficiency, has been observed for the memory deficit, which extends to both short-and long-term momory. Comparisons with normal siblings have confirmed the reduced QOL, although differences have been small. There is less consensus for a reduction in QOL when hypopituitary subjects are compared with patients with other chronic diseases, with studies supporting (in comparison with diabetics) and refuting (in comparison with patients following mastoid surgery) the reduction in QOL. GH replacement in adult has improved QOL, particularly in the domains of energy level and self-esteem, and memory has improved. The social impact of these changes may be considerable, with patients requiring fewer days' sick leave. A major placebo effect is present, however, and neutral results as well as positive have been reported in placebo-controlled trials. Where a positive effect has been observed, it has been more likely to occur in patients with a low QOL at the outset. It is otherwise impossible to predict at the outset those who will benefit from GH replacement. GH treatment has effects on body composition, exercise capacity, muscle strength, total body water and intermediary metabolism which would be expected to improve QOL. Replacement therapy also has side-effects, and it is the variable balance of the positive and negative effects, coupled with the difficulties of measuring QOL, which have led to the disparate results in the literature. There is probably also a true inter-individual variation, although the mechanisms of this are currently unknown.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信